Stay updated with breaking news from Apex Innovative Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Cognitive Research Corporation ("CRC"), a leading Central Nervous System (CNS)-focused clinical research and drug development organization...
- Topline data for pivotal Phase 3 trial evaluating brilaroxazine for the treatment of schizophrenia remains on track for mid-2023 – - Completed...
30.03.2023 - - Topline data for pivotal Phase 3 trial evaluating brilaroxazine for the treatment of schizophrenia remains on track for mid-2023 – - Completed majority of non-clinical and clinical prelaunch measures for brilaroxazine New Drug ...
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Premier CNS-Focused Research Facilities in California and New Jersey Join the CenExel Centers of Excellence Clinical Research Site Network...